Home
Mail
News
Sports
Finance
Celebrity
Style
Movies
Weather
Mobile
Yahoo
Mail
News
Taxes
Watchlists
My Portfolio
My Screeners
Market Data
Industry News
Sponsored: Small Business Insurance Hub
Real Estate
Technology
Currency Converter
Canada markets closed
S&P/TSX
21,947.41
+124.19
(+0.57%)
S&P 500
5,127.79
+63.59
(+1.26%)
DOW
38,675.68
+450.02
(+1.18%)
CAD/USD
0.7308
-0.0006
(-0.08%)
CRUDE OIL
77.99
-0.96
(-1.22%)
Bitcoin CAD
87,096.84
-680.21
(-0.77%)
Avalo Therapeutics, Inc. (AVTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
14.36
-1.54
(-9.69%)
At close: 04:00PM EDT
14.20
-0.16
(-1.11%)
After hours:
05:46PM EDT
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,924
1,924
18,051
5,398
6,699
Cost of Revenue
1,284
1,284
3,434
1,491
300
Gross Profit
640
640
14,617
3,907
6,399
Operating Expenses
Research Development
13,784
13,784
31,308
59,835
32,193
Selling General and Administrative
10,300
10,300
20,711
24,658
19,759
Total Operating Expenses
24,084
24,084
52,057
86,041
53,693
Operating Income or Loss
-23,444
-23,444
-37,440
-82,134
-47,294
Interest Expense
3,417
3,417
4,170
2,391
-
Total Other Income/Expenses Net
-4,669
-4,669
-20
-20
-19,932
Income Before Tax
-31,530
-31,530
-41,630
-84,545
-67,177
Income Tax Expense
14
14
28
-196
-2,793
Income from Continuing Operations
-31,544
-31,544
-41,658
-84,349
-64,384
Net Income
-31,544
-31,544
-41,658
-84,376
-63,500
Net Income available to common shareholders
-31,544
-31,544
-41,658
-84,376
-57,638
Basic EPS
-480.00
-114.00
-1.06k
-2.39k
-2.48k
Diluted EPS
-480.00
-114.00
-1.06k
-2.39k
-2.48k
Basic Average Shares
85.69
277.727
39.202
35.298
1,283
Diluted Average Shares
85.69
277.727
39.202
35.298
1,283
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy Dashboard
About Our Ads
© 2024 Yahoo. All rights reserved.